Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
1.500
-0.860 (-36.44%)
At close: Jun 26, 2026, 4:00 PM EDT
1.850
+0.350 (23.33%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Tvardi Therapeutics Employees
Tvardi Therapeutics had 12 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,286,583
Market Cap
14.07M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12 | 0 | - |
| Dec 31, 2024 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Longeveron | 38 |
| Palatin Technologies | 29 |
| Lipocine | 14 |
| Cellectar Biosciences | 11 |
| VYNE Therapeutics | 10 |
| Neuphoria Therapeutics | 8 |
| Allarity Therapeutics | 8 |
TVRD News
- 19 days ago - Tvardi Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 5 weeks ago - Tvardi Therapeutics to Participate in Upcoming Investor Events - GlobeNewsWire
- 7 weeks ago - Tvardi Therapeutics reports Q1 EPS (73c), consensus (72c) - TheFly
- 7 weeks ago - Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Tvardi Therapeutics files $200M mixed securities shelf - TheFly
- 2 months ago - Tvardi Therapeutics downgraded to Underweight from Equal Weight at Barclays - TheFly
- 3 months ago - Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium - GlobeNewsWire
- 3 months ago - Tvardi Therapeutics price target lowered to $3 from $4 at Piper Sandler - TheFly